Starch and albumin mixture as replacement fluid in therapeutic plasma exchange is safe and effective. (åpner nytt vindu)

Agreda-Vásquez GP, Espinosa-Poblano I, Sánchez-Guerrero SA, Crespo-Solís E, Cabrera-Vásquez S, López-Salmorán J, Barajas J, Peñaloza-Ramírez P, Tirado-Cárdenas N, Velázquez A.

Kilde‎: J Clin Apher 2008;23(5):163-7.

Arkiv‎: PubMed 18819155

DOI‎: 10.1002/jca.20175

https://www.ncbi.nlm.nih.gov/pubmed/18819155 (åpner nytt vindu)

Hydroxyethylstarch as a replacement fluid in therapeutic plasma exchange for lupus nephritis in a Jehovah's Witness. (åpner nytt vindu)

Cid J, Ortín X, Elies E, Díaz E.

Kilde‎: Transfus Apher Sci 2003;28(1):101-2.

Arkiv‎: PubMed 12620275

DOI‎: 10.1016/S1473-0502(02)00105-2

https://www.ncbi.nlm.nih.gov/pubmed/12620275 (åpner nytt vindu)

Treatment of thrombotic thrombocytopenic purpura with the cryosupernatant fraction of plasma: a case report and review of the literature. (åpner nytt vindu)

Ellis J, Theodossiou C, Schwarzenberger P.

Kilde‎: Am J Med Sci 1999;318(3):190-3.

Arkiv‎: PubMed 10487410

https://www.ncbi.nlm.nih.gov/pubmed/10487410 (åpner nytt vindu)

Pentastarch as partial replacement fluid for therapeutic plasma exchange: effect on plasma proteins, adverse events during treatment, and serum ionized calcium. (åpner nytt vindu)

Goss GA, Weinstein R.

Kilde‎: J Clin Apher 1999;14(3):114-21.

Arkiv‎: PubMed 10540365

https://www.ncbi.nlm.nih.gov/pubmed/10540365 (åpner nytt vindu)

Immunoadsorption in Guillain-Barré syndrome and myasthenia gravis. (åpner nytt vindu)

Haupt WF, Rosenow F, van der Ven C, Birkmann C.

Kilde‎: Ther Apher 2000;4(3):195-7.

Arkiv‎: PubMed 10910018

https://www.ncbi.nlm.nih.gov/pubmed/10910018 (åpner nytt vindu)

Replacement fluids in plasmapheresis: cross-over comparative study. (åpner nytt vindu)

Le Conte P, Nicolas F, Adjou C, N'Guyen JM, Billaud E, Moreau P.

Kilde‎: Intensive Care Med 1997;23(3):342-4.

Arkiv‎: PubMed 9083239

https://www.ncbi.nlm.nih.gov/pubmed/9083239 (åpner nytt vindu)

Tryptophan-immobilized column-based immunoadsorption as the choice method for plasmapheresis in Guillain-Barré syndrome. (åpner nytt vindu)

Okamiya S, Ogino M, Ogino Y, Irie S, Kanazawa N, Saito T, Sakai F.

Kilde‎: Ther Apher Dial 2004;8(3):248-53.

Arkiv‎: PubMed 15154879

DOI‎: 10.1111/j.1526-0968.2004.00138.x

https://www.ncbi.nlm.nih.gov/pubmed/15154879 (åpner nytt vindu)

Pentastarch instead of albumin as replacement fluid for therapeutic plasma exchange. The Canadian Apheresis Group. (åpner nytt vindu)

Rock G, Sutton DM, Freedman J, Nair RC.

Kilde‎: J Clin Apher 1997;12(4):165-9.

Arkiv‎: PubMed 9483177

https://www.ncbi.nlm.nih.gov/pubmed/9483177 (åpner nytt vindu)